Ireland
--:--IST
Starting soon Not applicable

Family-partnered Delirium Prevention, Detection, and Management in the ICU

NCT07896356 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2027-02-01
Last updated
2026-10-27

Condition(s) studied

DeliriumIntensive Care Unit DeliriumPost Intensive Care Unit SyndromePost Intensive Care Unit Syndrome Family

Investigational drug(s) / intervention(s)

Standard of CareDelirium Education, Prevention, and Management

Standard of Care: Patients and family caregivers will receive standard of care, which varies by study site, but includes guideline-recommended interventions by the clinical team to prevent and manage delirium.

Delirium Education, Prevention, and Management: Patients and family caregivers will be provided with a validated education module on the signs and risk factors of delirium, in addition to delirium detection, prevention, and management strategies. The material will be provided as a six-minute video or as a paper booklet. Families will practice identifying delirium with the Family ICU Delirium Detection Instrument (FIDDI), using previously validated case vignettes of hypothetical ICU patients. Family caregivers will also be provided with a daily checklist to complete, detailing non-pharmacological strategies to prevent and manage delirium (i.e., orientation, mobility, and environmental cues). Delirium detection by family caregivers will be assessed by the FIDDI and communicated to the bedside nurse.

Study summary

Almost half of critically ill patients experience delirium. Delirium is associated with impaired cognition, mortality, and increased healthcare costs. Family members of critically ill patients are also at risk for adverse consequences such as depression and anxiety.

One strategy that may help to improve outcomes is to engage family members in the prevention, detection, and management of delirium. This study will employ an educational module to educate families on delirium symptoms, how delirium can be identified, and how to prevent and manage delirium using non-pharmacological strategies.

Family member delirium detection may result in earlier and more accurate recognition of delirium as well as meaningful family involvement, and ultimately the potential for better patient and family outcomes. This study aims to determine the efficacy of employing family-administered delirium prevention, detection, and management in the critically ill, compared to standard of care. We hypothesize that family-administered delirium prevention, detection, and management in the critically ill will be superior to standard of care in:

1. Reducing psychological distress in family members,
2. Reducing the prevalence, duration, and severity of delirium in critically ill patients,
3. Increasing delirium identification in medical charts,
4. Increasing delirium knowledge in family members of critically ill patients, and
5. Reducing the burden of delirium experienced by family members and caregivers

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Patient Inclusion Criteria: * 18 years of age or older * Richmond Agitation-Sedation Scale (RASS) score of equal to or greater than -3 * Anticipated to remain admitted to the ICU for at least a further 48 hours to complete study assessments at least once * Family involvement * Able to communicate with research staff (in English or French, or with the assistance of a translator or interpreter) * Able to provide informed consent (surrogate consent possible) Family Inclusion Criteria: * 18 years of age or older * Able to communicate with research staff (in English or French, or with the assistance of a translator or interpreter) * Available at least once daily for up to five study days (study days do not have to be continuous) Patient Exclusion Criteria: * Deep sedation or coma (RASS score of -4 or -5) * Anticipated to remain admitted to the ICU for less than 48 hours * Moderate or severe traumatic brain injury (as judged by the most responsible physician or a designated clinical physician involved in the patient's care) * Already admitted to the ICU during study control or intervention periods (i.e., no readmissions) * Moribund

Primary outcome measure(s)

  • Family member symptoms of depression and anxiety — 3-months post-ICU discharge
    Change in the proportion of major depressive disorder and generalized anxiety symptamology in family members of critical ill patients measured by the Patient Health Questionnaire-Anxiety and Depression Scale (PHQ-ADS) scores, compared between control and intervention

Trial sites (1)

FacilityCityRegionStatus
Foothills Medical Centre Calgary Alberta
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07896356 on ClinicalTrials.gov ↗ ← All trials in Canada